Spine, the leading scientific journal for research on back pain, has published results from Stayble Therapeutic’s studies with STA363. The results show that STA363 induces connective tissue transformation in the spinal disc. This is the company’s goal in order to be able to treat patients who suffer from chronic disc-related back pain and who are not helped by physiotherapy and painkillers.
Read the full article at biostock.se:
This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se